Pharmacology of fibrosis: definitions, limits and perspectives.
D000629:Aminopropionitrile / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D001206:Ascorbic Acid Deficiency / Q000378:metabolism; D001704:Biopolymers / Q000096:biosynthesis; D002462:Cell Membrane / Q000502:physiology; D002921:Cicatrix / Q000188:drug therapy* / Q000378:metabolism; D003094:Collagen / Q000378:metabolism*; D003238:Connective Tissue / Q000187:drug effects; D004341:Drug Evaluation; D005347:Fibroblasts / Q000187:drug effects / Q000276:immunology / Q000378:metabolism; D006801:Humans; D006900:Hydroxylation; D007106:Immune Sera / Q000494:pharmacology; D007249:Inflammation / Q000188:drug therapy* / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use; D050356:Lipid Metabolism; D008247:Lysosomes / Q000502:physiology; D010545:Peroxides / Q000378:metabolism; D011392:Proline / Q000031:analogs & derivatives / Q000627:therapeutic use; D012598:Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D015032:Zinc / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000975:Antioxidants; D001704:Biopolymers; D007106:Immune Sera; D007502:Iron Chelating Agents; D010545:Peroxides; D000629:Aminopropionitrile; D003094:Collagen; D011392:Proline; D015032:Zinc